These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
291 related articles for article (PubMed ID: 25620093)
1. Imidazoles and benzimidazoles as tubulin-modulators for anti-cancer therapy. Torres FC; García-Rubiño ME; Lozano-López C; Kawano DF; Eifler-Lima VL; von Poser GL; Campos JM Curr Med Chem; 2015; 22(11):1312-23. PubMed ID: 25620093 [TBL] [Abstract][Full Text] [Related]
2. A new class of cytotoxic agents targets tubulin and disrupts microtubule dynamics. Al-Hamashi AA; Koranne R; Dlamini S; Alqahtani A; Karaj E; Rashid MS; Knoff JR; Dunworth M; Pflum MKH; Casero RA; Perera L; Taylor WR; Tillekeratne LMV Bioorg Chem; 2021 Nov; 116():105297. PubMed ID: 34509798 [TBL] [Abstract][Full Text] [Related]
3. Microtubule Targeting Agents as Cancer Chemotherapeutics: An Overview of Molecular Hybrids as Stabilizing and Destabilizing Agents. Tangutur AD; Kumar D; Krishna KV; Kantevari S Curr Top Med Chem; 2017; 17(22):2523-2537. PubMed ID: 28056738 [TBL] [Abstract][Full Text] [Related]
4. The novel microtubule-destabilizing drug BAL27862 binds to the colchicine site of tubulin with distinct effects on microtubule organization. Prota AE; Danel F; Bachmann F; Bargsten K; Buey RM; Pohlmann J; Reinelt S; Lane H; Steinmetz MO J Mol Biol; 2014 Apr; 426(8):1848-60. PubMed ID: 24530796 [TBL] [Abstract][Full Text] [Related]
5. New benzimidazole-2-urea derivates as tubulin inhibitors. Wang W; Kong D; Cheng H; Tan L; Zhang Z; Zhuang X; Long H; Zhou Y; Xu Y; Yang X; Ding K Bioorg Med Chem Lett; 2014 Sep; 24(17):4250-3. PubMed ID: 25091926 [TBL] [Abstract][Full Text] [Related]
6. Discovery of benzimidazole-2-amide BNZ-111 as new tubulin inhibitor. Jang J; Koh B; Lee K Bioorg Med Chem Lett; 2024 Nov; 113():129953. PubMed ID: 39270806 [TBL] [Abstract][Full Text] [Related]
7. [Progress in the study of tubulin inhibitors]. Shang H; Pan L; Yang S; Chen H; Cheng MS Yao Xue Xue Bao; 2010 Sep; 45(9):1078-88. PubMed ID: 21351562 [TBL] [Abstract][Full Text] [Related]
8. Discovery of novel 2-phenyl-imidazo[1,2-a]pyridine analogues targeting tubulin polymerization as antiproliferative agents. An W; Wang W; Yu T; Zhang Y; Miao Z; Meng T; Shen J Eur J Med Chem; 2016 Apr; 112():367-372. PubMed ID: 26927488 [TBL] [Abstract][Full Text] [Related]
9. Synthesis, antiproliferative activity and molecular docking of thiocolchicine urethanes. Majcher U; Urbaniak A; Maj E; Moshari M; Delgado M; Wietrzyk J; Bartl F; Chambers TC; Tuszynski JA; Huczyński A Bioorg Chem; 2018 Dec; 81():553-566. PubMed ID: 30248507 [TBL] [Abstract][Full Text] [Related]
10. Synthesis and biological evaluation of imidazo[2,1-b]thiazole-benzimidazole conjugates as microtubule-targeting agents. Baig MF; Nayak VL; Budaganaboyina P; Mullagiri K; Sunkari S; Gour J; Kamal A Bioorg Chem; 2018 Apr; 77():515-526. PubMed ID: 29459129 [TBL] [Abstract][Full Text] [Related]
11. Synthesis and evaluation of new 2-chloro-4-aminopyrimidine and 2,6-dimethyl-4-aminopyrimidine derivatives as tubulin polymerization inhibitors. Xu S; An B; Li Y; Luo X; Li X; Jia X Bioorg Med Chem Lett; 2018 Jun; 28(10):1769-1775. PubMed ID: 29673981 [TBL] [Abstract][Full Text] [Related]
12. Quinolin-6-Yloxyacetamides Are Microtubule Destabilizing Agents That Bind to the Colchicine Site of Tubulin. Sharma A; Sáez-Calvo G; Olieric N; de Asís Balaguer F; Barasoain I; Lamberth C; Díaz JF; Steinmetz MO Int J Mol Sci; 2017 Jun; 18(7):. PubMed ID: 28640209 [TBL] [Abstract][Full Text] [Related]
13. Synthesis and evaluation of benzimidazole carbamates bearing indole moieties for antiproliferative and antitubulin activities. Guan Q; Han C; Zuo D; Zhai M; Li Z; Zhang Q; Zhai Y; Jiang X; Bao K; Wu Y; Zhang W Eur J Med Chem; 2014 Nov; 87():306-15. PubMed ID: 25262051 [TBL] [Abstract][Full Text] [Related]
14. Recent advances in research of colchicine binding site inhibitors and their interaction modes with tubulin. Sun K; Sun Z; Zhao F; Shan G; Meng Q Future Med Chem; 2021 May; 13(9):839-858. PubMed ID: 33821673 [TBL] [Abstract][Full Text] [Related]
15. Discovery of novel 2-aryl-4-benzoyl-imidazole (ABI-III) analogues targeting tubulin polymerization as antiproliferative agents. Chen J; Ahn S; Wang J; Lu Y; Dalton JT; Miller DD; Li W J Med Chem; 2012 Aug; 55(16):7285-9. PubMed ID: 22783954 [TBL] [Abstract][Full Text] [Related]
16. Development of a novel class of tubulin inhibitor from desmosdumotin B with a hydroxylated bicyclic B-ring. Nakagawa-Goto K; Oda A; Hamel E; Ohkoshi E; Lee KH; Goto M J Med Chem; 2015 Mar; 58(5):2378-89. PubMed ID: 25695315 [TBL] [Abstract][Full Text] [Related]
17. Design, synthesis, and biological evaluation of combretabenzodiazepines: a novel class of anti-tubulin agents. Galli U; Travelli C; Aprile S; Arrigoni E; Torretta S; Grosa G; Massarotti A; Sorba G; Canonico PL; Genazzani AA; Tron GC J Med Chem; 2015 Feb; 58(3):1345-57. PubMed ID: 25584687 [TBL] [Abstract][Full Text] [Related]
18. Synthesis and biological evaluation as microtubule-active agents of several tetrahydrofuran and spiroacetal derivatives. Carda M; Murga J; Paños J; Angulo-Pachón CA; García-Pla J; Díaz-Oltra S; Marco JA; Trigili C; Redondo-Horcajo M; Díaz JF; Barasoain I Curr Med Chem; 2013; 20(9):1173-82. PubMed ID: 23317099 [TBL] [Abstract][Full Text] [Related]
19. 4(1H)-quinolone derivatives overcome acquired resistance to anti-microtubule agents by targeting the colchicine site of β-tubulin. Lin MS; Hong TM; Chou TH; Yang SC; Chung WC; Weng CW; Tsai ML; Cheng TR; Chen JJW; Lee TC; Wong CH; Chein RJ; Yang PC Eur J Med Chem; 2019 Nov; 181():111584. PubMed ID: 31419740 [TBL] [Abstract][Full Text] [Related]
20. Synthesis and antiproliferative activity of novel 2-aryl-4-benzoyl-imidazole derivatives targeting tubulin polymerization. Chen J; Li CM; Wang J; Ahn S; Wang Z; Lu Y; Dalton JT; Miller DD; Li W Bioorg Med Chem; 2011 Aug; 19(16):4782-95. PubMed ID: 21775150 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]